Partner Content Partner Content Just two weeks to go until SMi’s flagship Pharmaceutical Mic... Just two weeks to go until Pharma Microbioloigy UK
News Roche expands phase 3 plans for Alzheimer's drug Roche has added a phase 3 trial of trontinemab, hoping to show it can delay or prevent progression to Alzheimer's symptoms in preclinical patients.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
